182 related articles for article (PubMed ID: 35381971)
41. A Single-Run Next-Generation Sequencing (NGS) Assay for the Simultaneous Detection of Both Gene Mutations and Large Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes (MDS) and Related Myeloid Neoplasms.
Liquori A; Lesende I; Palomo L; Avetisyan G; Ibáñez M; González-Romero E; Boluda-Navarro M; Morote-Faubel M; Garcia-Ruiz C; Martinez-Valiente C; Santiago-Balsera M; Gomez-Seguí I; Sanjuan-Pla A; Sanz MA; Sanz G; Solé F; Such E; Cervera J
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919541
[TBL] [Abstract][Full Text] [Related]
42. Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations.
Liu YC; Illar GM; Bailey NG
J Clin Pathol; 2020 Nov; 73(11):728-736. PubMed ID: 32217616
[TBL] [Abstract][Full Text] [Related]
43. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
44. Next-generation sequencing and molecular cytogenetic characterization of ETV6-LYN fusion due to chromosomes 1, 8 and 12 rearrangement in acute myeloid leukemia.
Ma ESK; Wan TSK; Au CH; Ho DN; Ma SY; Ng MHL; Chan TL
Cancer Genet; 2017 Dec; 218-219():15-19. PubMed ID: 29153093
[TBL] [Abstract][Full Text] [Related]
45. NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.
Forghieri F; Paolini A; Morselli M; Bigliardi S; Bonacorsi G; Leonardi G; Coluccio V; Maccaferri M; Fantuzzi V; Faglioni L; Colaci E; Soci F; Nasillo V; Messerotti A; Arletti L; Pioli V; Zucchini P; Quadrelli C; Corradini G; Giacobbi F; Vallerini D; Riva G; Barozzi P; Lagreca I; Marasca R; Narni F; Mecucci C; Ottaviani E; Martinelli G; Falini B; Luppi M; Potenza L
Leuk Lymphoma; 2015; 56(11):3222-6. PubMed ID: 25813079
[No Abstract] [Full Text] [Related]
46. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
[TBL] [Abstract][Full Text] [Related]
47. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
Au CH; Wa A; Ho DN; Chan TL; Ma ES
Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
[TBL] [Abstract][Full Text] [Related]
48. Analysis of genetic variants in myeloproliferative neoplasms using a 22-gene next-generation sequencing panel.
Tan J; Chow YP; Zainul Abidin N; Chang KM; Selvaratnam V; Tumian NR; Poh YM; Veerakumarasivam A; Laffan MA; Wong CL
BMC Med Genomics; 2022 Jan; 15(1):10. PubMed ID: 35033063
[TBL] [Abstract][Full Text] [Related]
49. Detection of Hybrid Fusion Transcripts, Aberrant Transcript Expression, and Specific Single Nucleotide Variants in Acute Leukemia and Myeloid Disorders with Recurrent Gene Rearrangements.
Li Y; Deng K; Kaner J; Geyer JT; Ouseph M; Fang F; Xu K; Roboz G; Kluk MJ
Pathobiology; 2024; 91(1):76-88. PubMed ID: 37490880
[TBL] [Abstract][Full Text] [Related]
50. Next-generation sequencing-based minimal residual disease monitoring in patients receiving allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia or myelodysplastic syndrome.
Shapiro RM; Kim DDH
Curr Opin Hematol; 2018 Nov; 25(6):425-432. PubMed ID: 30281033
[TBL] [Abstract][Full Text] [Related]
51. Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions.
DeZern AE; Goll JB; Lindsley RC; Bejar R; Wilson SH; Hebert D; Deeg J; Zhang L; Gore S; Al Baghdadi T; Maciejewski J; Liu J; Padron E; Komrojki R; Saber W; Abel G; Kroft SH; Harrington A; Grimes T; Reed H; Fulton RS; DiFronzo NL; Gillis N; Sekeres MA; Walter MJ
Blood Adv; 2023 Jul; 7(14):3749-3759. PubMed ID: 36947201
[TBL] [Abstract][Full Text] [Related]
52. Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide.
Sugimoto Y; Sekeres MA; Makishima H; Traina F; Visconte V; Jankowska A; Jerez A; Szpurka H; O'Keefe CL; Guinta K; Afable M; Tiu R; McGraw KL; List AF; Maciejewski J
J Hematol Oncol; 2012 Mar; 5():4. PubMed ID: 22390313
[TBL] [Abstract][Full Text] [Related]
53. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
[TBL] [Abstract][Full Text] [Related]
54. Clinical utility and real-world application of molecular genetic sequencing in the management of patients with acute myeloid leukemia and myelodysplastic syndromes.
Banaszak LG; Reinig E; Lasarev MR; Mattison RJ
Leuk Lymphoma; 2022 Mar; 63(3):684-693. PubMed ID: 34865601
[TBL] [Abstract][Full Text] [Related]
55. Next generation sequencing in therapy-related myeloid neoplasms compared to
Claerhout H; Vranckx H; Lierman E; Michaux L; Boeckx N
Acta Clin Belg; 2022 Jun; 77(3):658-663. PubMed ID: 34197279
[TBL] [Abstract][Full Text] [Related]
56. Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome-excess blasts detected by next-generation sequencing technique.
Owattanapanich W; Herzig J; Jahn N; Panina E; Ruchutrakool T; Kungwankiattichai S; Issaragrisil S; Döhner H; Döhner K
Ann Hematol; 2021 Aug; 100(8):1983-1993. PubMed ID: 33839881
[TBL] [Abstract][Full Text] [Related]
57. The evolving role of next generation sequencing in myelodysplastic syndromes.
Spaulding TP; Stockton SS; Savona MR
Br J Haematol; 2020 Jan; 188(2):224-239. PubMed ID: 31571207
[TBL] [Abstract][Full Text] [Related]
58. Molecular genetics of MDS/MPN overlap syndromes.
Hunter AM; Padron E
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101195. PubMed ID: 33038984
[TBL] [Abstract][Full Text] [Related]
59. The Dawn of next generation DNA sequencing in myelodysplastic syndromes- experience from Pakistan.
Anwar N; Memon FA; Shahid S; Shakeel M; Irfan M; Arshad A; Naz A; Ujjan ID; Shamsi T
BMC Genomics; 2021 Dec; 22(1):903. PubMed ID: 34915860
[TBL] [Abstract][Full Text] [Related]
60. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Nardi V; Hasserjian RP
Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
